[Hepato-biliary effect of the rifomycin-prothionamid combination. I. Histological study on the rat].
D000818:Animals; D000995:Antitubercular Agents / Q000633:toxicity*; D004357:Drug Synergism; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D007538:Isoniazid / Q000633:toxicity; D008099:Liver / Q000187:drug effects*; D008297:Male; D051381:Rats; D012293:Rifampin / Q000633:toxicity*
D000995:Antitubercular Agents; D005227:Fatty Acids; D007538:Isoniazid; D012293:Rifampin
Effets hépato-biliaires de l'association rifampicine-prothionamide. I. Etude histologique chez le rat.